ESSENT BIOLOGICS RELEASES AMNION FOUNDATION’S FIRST HUMAN PRE-ECLAMPTIC PRIMARY CYTOTROPHOBLASTS AND HOFBAUER CELLS

Providing Researchers with Breakthrough Materials to Investigate Pre-Eclampsia CENTENNIAL, Colo., Aug. 23, 2022 /PRNewswire/ — Essent Biologics™, a leading supplier of human-derived cell and scaffold materials, today announced availability for investigational researchers to obtain human…

Click here to view original post